Sunday, 1 September 2013

Bayer’s Stivarga® (regorafenib) Tablets Approved in Europe « New Drug Approvals

Bayer’s Stivarga® (regorafenib) Tablets Approved in Europe « New Drug Approvals:

'via Blog this'

Otsuka Receives Complete Response Letter From U.S. Food And Drug Administration For Tolvaptan For Use In Patients With Autosomal Dominant Polycystic Kidney Disease « New Drug Approvals

Otsuka Receives Complete Response Letter From U.S. Food And Drug Administration For Tolvaptan For Use In Patients With Autosomal Dominant Polycystic Kidney Disease « New Drug Approvals:

'via Blog this'

GLIPTINS: BETTER APPROACH FOR TYPE 2 DIABETES « New Drug Approvals

GLIPTINS: BETTER APPROACH FOR TYPE 2 DIABETES « New Drug Approvals:

'via Blog this'

Blueberries, not fruit juice, cut type-2 diabetes risk « New Drug Approvals

Blueberries, not fruit juice, cut type-2 diabetes risk « New Drug Approvals:

'via Blog this'

European Commission Approves Genzyme’s Once-Daily, Oral Multiple Sclerosis Treatment Aubagio® (teriflunomide) « New Drug Approvals

European Commission Approves Genzyme’s Once-Daily, Oral Multiple Sclerosis Treatment Aubagio® (teriflunomide) « New Drug Approvals